AU Patent

AU2014302458A1 — Methods of modulating CFTR activity

Assigned to Kineta Inc · Expires 2015-12-24 · 10y expired

What this patent protects

The invention encompasses methods of modulating CFTR activity in a subject in need thereof comprising administering an effective amount of a compound of Formula (I). The invention also encompasses methods of treating a condition associated with CFTR activity or condition associat…

USPTO Abstract

The invention encompasses methods of modulating CFTR activity in a subject in need thereof comprising administering an effective amount of a compound of Formula (I). The invention also encompasses methods of treating a condition associated with CFTR activity or condition associated with a dysfunction of proteostasis comprising administering to a subject an effective amount of a compound of Formula (I).

Drugs covered by this patent

Patent Metadata

Patent number
AU2014302458A1
Jurisdiction
AU
Classification
—
Expires
2015-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Kineta Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.